SB 2318 – Rhode Island

Status: Inactive / Dead
Year Introduced: 2020

This act would require pharmaceutical drug manufacturers to provide wholesale drug acquisition cost information to the department of health (DOH) and pharmacy benefit managers to provide information relating to drug prices, rebates, fees and drug sales to the health insurance commissioner on a yearly basis on or before February 1, 2021 and thereafter.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found